D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
GILD holding history
Gilead Sciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GILD overviewAll 13F holders of GILDFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,294,789
- Value
- $289.9M
- % of portfolio
- 0.2%
- Quarters held
- 20
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,294,789 | $289.9M | 0.2% | +2,093,870+1,042.1% | Added | Holders |
| Q1 2026 | 200,919 | $28.0M | <0.1% | +8,214+4.3% | Added | Holders |
| Q4 2025 | 192,705 | $23.7M | <0.1% | −221,057−53.4% | Reduced | Holders |
| Q3 2025 | 413,762 | $45.9M | <0.1% | −286,466−40.9% | Reduced | Holders |
| Q2 2025 | 700,228 | $77.6M | 0.1% | +246,472+54.3% | Added | Holders |
| Q1 2025 | 453,756 | $50.8M | 0.1% | −558,706−55.2% | Reduced | Holders |
| Q4 2024 | 1,012,462 | $93.5M | 0.1% | +271,261+36.6% | Added | Holders |
| Q3 2024 | 741,201 | $62.1M | 0.1% | −2,597,051−77.8% | Reduced | Holders |
| Q2 2024 | 3,338,252 | $229.0M | 0.3% | +2,203,342+194.1% | Added | Holders |
| Q1 2024 | 1,134,910 | $83.1M | 0.1% | +178,269+18.6% | Added | Holders |
| Q4 2023 | 956,641 | $77.5M | 0.1% | −1,373,449−58.9% | Reduced | Holders |
| Q3 2023 | 2,330,090 | $174.6M | 0.3% | +279,963+13.7% | Added | Holders |
| Q2 2023 | 2,050,127 | $158.0M | 0.2% | +212,149+11.5% | Added | Holders |
| Q1 2023 | 1,837,978 | $152.5M | 0.2% | −178,062−8.8% | Reduced | Holders |
| Q4 2022 | 2,016,040 | $173.1M | 0.3% | +1,563,996+346.0% | Added | Holders |
| Q3 2022 | 452,044 | $27.9M | <0.1% | −1,319,616−74.5% | Reduced | Holders |
| Q2 2022 | 1,771,660 | $109.5M | 0.2% | −3,373,926−65.6% | Reduced | Holders |
| Q1 2022 | 5,145,586 | $305.9M | 0.4% | +4,454,256+644.3% | Added | Holders |
| Q4 2021 | 691,330 | $50.2M | 0.1% | +691,330 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −609,167−100.0% | Sold out | Holders |
| Q1 2021 | 609,167 | $39.4M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.